NASDAQ · HYPR
Healthcare · Medical - Devices
$0.69
Up+$0.06 (+8.36%)
Updated Nov 4, 2026, 11:20 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HYPR
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
HYPR closed at $0.69 after 21 trading sessions, down 20.41% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $0.724 | $0.724 | $0.6674 | $0.6924 | 1.31M |
| Nov 2, 2026 | $0.7238 | $0.7395 | $0.71 | $0.7247 | 198.66K |
| Oct 30, 2026 | $0.73 | $0.7515 | $0.71 | $0.7176 | 565.6K |
| Oct 29, 2026 | $0.7799 | $0.7799 | $0.7347 | $0.7436 | 680.38K |
| Oct 28, 2026 | $0.7536 | $0.7849 | $0.72 | $0.7846 | 939.06K |
| Oct 27, 2026 | $0.746 | $0.7596 | $0.7131 | $0.7497 | 479.32K |
| Oct 26, 2026 | $0.7244 | $0.7434 | $0.713 | $0.7232 | 239.01K |
| Oct 23, 2026 | $0.711 | $0.7293 | $0.6955 | $0.7244 | 428.03K |
| Oct 22, 2026 | $0.731 | $0.7505 | $0.705 | $0.7258 | 504.8K |
| Oct 21, 2026 | $0.7726 | $0.7796 | $0.7221 | $0.7463 | 501.33K |
| Oct 20, 2026 | $0.76 | $0.7771 | $0.7501 | $0.774 | 274.24K |
| Oct 19, 2026 | $0.7601 | $0.7812 | $0.74 | $0.7772 | 342.89K |
| Oct 16, 2026 | $0.79 | $0.79 | $0.7406 | $0.7548 | 559.6K |
| Oct 15, 2026 | $0.80 | $0.8122 | $0.761 | $0.7801 | 950.24K |
| Oct 14, 2026 | $0.85 | $0.8551 | $0.80 | $0.8001 | 778.73K |
| Oct 13, 2026 | $0.89 | $0.9007 | $0.85 | $0.8515 | 536.75K |
| Oct 12, 2026 | $0.93 | $0.93 | $0.8756 | $0.9064 | 990.98K |
| Oct 9, 2026 | $0.9591 | $1.05 | $0.9302 | $0.9307 | 1.98M |
| Oct 8, 2026 | $0.99 | $0.9968 | $0.8406 | $0.9401 | 11.06M |
| Oct 7, 2026 | $0.846 | $0.8844 | $0.8406 | $0.849 | 477.78K |
| Oct 6, 2026 | $0.8992 | $0.9436 | $0.86 | $0.87 | 890.62K |
The latest Smart Investors Daily articles mentioning HYPR.
Company
Market Activity
Research & News
HYPR research
Company profile and research snapshot.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 27, 2026 | Lucid Capital Markets | Buy | — |
| Sep 22, 2026 | BTIG | Buy | — |
| Sep 14, 2026 | BTIG | Buy | — |
| Aug 10, 2026 | B. Riley Securities | Buy | — |
| Apr 29, 2026 | BTIG | Buy | — |
No generated briefing is available yet.
Benzinga · Apr 9, 2026
This milestone unlocks Hyperfine's most significant technology innovations to date for clinicians and patients across Europe and the United Kingdom, delivering a transformative leap in image quality and a major expansion
Benzinga · Jan 27, 2026
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
businesswire.com · Nov 20, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HYPR.
